These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 25685282)

  • 21. Effects of sugar-sweetened beverage intake on the development of type 2 diabetes mellitus in subjects with impaired glucose tolerance: the Mihama diabetes prevention study.
    Teshima N; Shimo M; Miyazawa K; Konegawa S; Matsumoto A; Onishi Y; Sasaki R; Suzuki T; Yano Y; Matsumoto K; Yamada T; Gabazza EC; Takei Y; Sumida Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):14-9. PubMed ID: 25994135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?
    Vaag A; Lund SS
    Appl Physiol Nutr Metab; 2007 Oct; 32(5):912-20. PubMed ID: 18059616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interorgan Crosstalk Contributing to
    Tanabe K; Amo-Shiinoki K; Hatanaka M; Tanizawa Y
    J Diabetes Res; 2017; 2017():3605178. PubMed ID: 28168202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses.
    Hong J; Gu WQ; Zhang YF; Yang YS; Shen CF; Xu M; Li XY; Wang WQ; Ning G
    Endocrine; 2007 Apr; 31(2):93-9. PubMed ID: 17873317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2010; 16(34):3939-847. PubMed ID: 21128892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function.
    Torres-Rasgado E; Porchia LM; Ruiz-Vivanco G; Gonzalez-Mejia ME; Báez-Duarte BG; Pulido-Pérez P; Rivera A; Romero JR; Pérez-Fuentes R
    Metab Syndr Relat Disord; 2015 Feb; 13(1):45-51. PubMed ID: 25423015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of weight gain on outcomes in type 2 diabetes.
    Ross SA; Dzida G; Vora J; Khunti K; Kaiser M; Ligthelm RJ
    Curr Med Res Opin; 2011 Jul; 27(7):1431-8. PubMed ID: 21599553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ; White RD
    J Fam Pract; 2007 Aug; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions to improve β-cell mass and function.
    Mondal P; Prasad A; Girdhar K
    Ann Endocrinol (Paris); 2017 Oct; 78(5):469-477. PubMed ID: 28870707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.
    Ji Q
    Clin Ther; 2017 Jun; 39(6):1244-1264. PubMed ID: 28526416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.
    Knop FK; Holst JJ; Vilsbøll T
    IDrugs; 2008 Jul; 11(7):497-501. PubMed ID: 18600596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network Cluster Analysis of Protein-Protein Interaction Network-Identified Biomarker for Type 2 Diabetes.
    Li Z; Qiao Z; Zheng W; Ma W
    Diabetes Technol Ther; 2015 Jul; 17(7):475-81. PubMed ID: 25879401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus.
    Belete TM
    J Exp Pharmacol; 2020; 12():1-15. PubMed ID: 32021494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass.
    Chon S; Gautier JF
    Diabetes Metab J; 2016 Apr; 40(2):99-114. PubMed ID: 27126881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
    Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between beta-cell mass and diabetes onset.
    Matveyenko AV; Butler PC
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4(0 4):23-31. PubMed ID: 18834430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adiposity and family history of type 2 diabetes in an admixed population of adolescents: Associations with insulin sensitivity, beta-cell function, and hepatic insulin extraction in BRAMS study.
    Camilo DF; Vasques ACJ; Hayashi K; Tura A; da Silva CC; Zambon MP; Antônio MÂRGM; Geloneze B
    Diabetes Res Clin Pract; 2018 Mar; 137():72-82. PubMed ID: 29320718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.